Back to top
more

Magellan Health, Inc. (MGLN)

(Delayed Data from NSDQ)

$74.98 USD

74.98
240,919

+2.55 (3.52%)

Updated Nov 19, 2019 03:56 PM ET

Add to portfolio

4-Sell       4  

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.62%
17.69%
9.40%
5.11%
2.01%
10.65%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

A Value | A Growth | C Momentum | A VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for MGLN

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Magellan Health, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Assets          
Cash & Equivalents 655 709 602 571 695
Receivables 756 661 607 429 354
Notes Receivable 0 0 0 0 0
Inventories 41 41 59 51 39
Other Current Assets 95 72 52 47 79
Total Current Assets 1,547 1,483 1,319 1,098 1,168
Net Property & Equipment 151 159 173 175 172
Investments & Advances 3 17 8 4 43
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 3 1 3 27 0
Intangibles 1,250 1,275 928 755 700
Deposits & Other Assets 25 23 13 11 12
Total Assets 2,979 2,957 2,444 2,069 2,094
Liabilities & Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Notes Payable 0 0 0 0 0
Accounts Payable 72 74 96 86 64
Current Portion Long-Term Debt 24 113 404 19 16
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 625 521 386 390 433
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 178 184 207 229 73
Total Current Liabilities 899 892 1,093 724 586
Mortgages 0 0 0 0 0
Deferred Taxes/Income 48 31 16 21 51
Convertible Debt 0 0 0 0 0
Long-Term Debt 729 741 215 238 256
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 19 16 16 13 62
Minority Interest (Liabilities) 0 0 5 6 6
Total Liabilities 1,694 1,681 1,344 1,003 961
Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,327 1,275 1,186 1,124 1,018
Retained Earnings 1,419 1,400 1,289 1,211 1,180
Other Equity -0 -0 -0 -0 -0
Treasury Stock 1,461 1,398 1,376 1,269 1,065
Total Shareholder's Equity 1,285 1,276 1,100 1,066 1,134
Total Liabilities & Shareholder's Equity 2,979 2,957 2,444 2,069 2,094
Total Common Equity 1,285 1,276 1,100 1,066 1,134
Shares Outstanding 24.20 24.00 23.20 25.50 27.60
Book Value Per Share 53.11 53.19 47.40 41.81 41.07

Fiscal Year End for Magellan Health, Inc. falls in the month of December.

All items in Millions except Per Share data.

9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Assets          
Cash & Equivalents 713 632 646 655 609
Receivables 813 810 780 756 821
Notes Receivable 0 0 0 0 0
Inventories 48 46 47 41 44
Other Current Assets 87 97 100 95 103
Total Current Assets 1,661 1,585 1,573 1,547 1,577
Net Property & Equipment 142 145 150 151 155
Investments & Advances 8 23 18 3 4
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 3 3 4 3 1
Intangibles 1,200 1,215 1,236 1,250 1,261
Deposits & Other Assets 129 107 91 25 51
Total Assets 3,142 3,078 3,071 2,979 3,049
Liabilities & Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Notes Payable 0 0 0 0 0
Accounts Payable 92 75 75 72 73
Current Portion Long-Term Debt 4 21 25 24 65
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 738 662 660 625 612
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 145 166 184 178 169
Total Current Liabilities 978 925 944 899 919
Mortgages 0 0 0 0 0
Deferred Taxes/Income 89 88 92 48 48
Convertible Debt 0 0 0 0 0
Long-Term Debt 695 713 723 729 734
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 16 19 19 16
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,779 1,744 1,778 1,694 1,717
Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,372 1,365 1,338 1,327 1,324
Retained Earnings 1,455 1,433 1,420 1,419 1,447
Other Equity 0 0 0 -0 -0
Treasury Stock 1,465 1,465 1,465 1,461 1,440
Total Shareholder's Equity 1,362 1,334 1,293 1,285 1,332
Total Liabilities & Shareholder's Equity 3,142 3,078 3,071 2,979 3,049
Total Common Equity 1,362 1,334 1,293 1,285 1,332
Shares Outstanding 24.40 24.40 24.00 24.20 24.20
Book Value Per Share 55.84 54.68 53.89 53.11 55.03